Clinical Trials Browser

Phase 1/2 × INDUSTRY × 3-ingenyl angelate × Clear all

NCT01803477 2025-02-24

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

Phase 1/2 Completed

Keratosis, Actinic